Accès à distance ? S'identifier sur le proxy UCLouvain
Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study
Primary tabs
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Access type | Accès restreint |
Publication date | 2012 |
Language | Anglais |
Journal information | "Journal of Clinical Oncology" - Vol. 30, no.23, p. 2861-2868 (2012) |
Peer reviewed | yes |
Publisher | American Society of Clinical Oncology ((United States) Alexandria) |
issn | 0732-183X |
e-issn | 1527-7755 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie UCL - (SLuc) Unité d'oncologie médicale |
MESH Subject | Aged ; Male ; Middle Aged ; Antibodies, Monoclonal ; Antineoplastic Combined Chemotherapy Protocols ; Camptothecin ; Colorectal Neoplasms ; Dose-Response Relationship, Drug ; Drug Eruptions ; Female ; Humans |
Links |
Bibliographic reference | Van Cutsem, Eric ; Tejpar, Sabine ; Vanbeckevoort, Dirk ; Peeters, Marc ; Humblet, Yves ; et. al. Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study. In: Journal of Clinical Oncology, Vol. 30, no.23, p. 2861-2868 (2012) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/124400 |